Home » Trials » SLCTR/2018/006
Randomised Controlled Trial on the effects of selected of positive expiratory pressure (PEP) breathing exercises with conventional breathing exercises in patients undergoing coronary artery bypass graft (CABG) surgery
-
SLCTR Registration Number
SLCTR/2018/006
Date of Registration
The date of last modification
Mar 03, 2019
Scientific Title of Trial
Randomised Controlled Trial on the effects of selected of positive expiratory pressure (PEP) breathing exercises with conventional breathing exercises in patients undergoing coronary artery bypass graft (CABG) surgery
Public Title of Trial
Comparison of the effects of different types of positive expiratory pressure (PEP) breathing exercises with conventional breathing exercises in patients undergoing coronary artery bypass graft (CABG) surgery in Sri Lanka
Disease or Health Condition(s) Studied
Post operative respiratory complications after CABG surgery
Scientific Acronym
None
Public Acronym
None
Brief title
Effectiveness of PEP exercises after CABG surgery
Universal Trial Number
U1111-1208-2939
Any other number(s) assigned to the trial and issuing authority
EC-16-215 (ERC: Colombo
What is the research question being addressed?
What are the effects of different types of positive expiratory pressure (PEP) breathing exercises when compared to conventional breathing exercises in patients undergoing coronary artery bypass graft (CABG) surgery?
Type of study
Interventional
Study design
Allocation
Randomized controlled trial
Masking
Masking not used
Control
Standard therapy/practice
Assignment
Parallel
Purpose
Prevention
Study Phase
Not Applicable
Intervention(s) planned
Study setting: National Hospital Sri Lanka (NHSL)
All patients who admit for CABG surgery in Cardiothoracic Units of NHSL will be consecutively screened for eligibility. Following recruitment, participants will be assigned in to 03 (three) groups (group A, B and C) randomly using sealed envelopes containing the group number. All the patients will be allocated in the study until sample size (180) obtained.
Intervention: Participants in groups A and B will attend sessions of positive expiratory pressure (PEP) exercises by the principal investigator starting from 2 days before surgery. The exercises will be demonstrated and supervised individually by the principal investigator from pre-operative day 2 until discharge from the ward.
Participants of Group C will receive standard management only. All the three groups will continue routine physiotherapy techniques conducted by the ward physiotherapists.
Group A: Commercialized PEP device group (used to create an expiratory resistance of +10 cm of H2O). The patients will be instructed to perform the exercises in the sitting position. Subjects will be instructed to perform slow maximal inspirations, while expiration will be through the device. The exercise session will include 3 sets of 10 deep breaths with 30 to 60 seconds pause between each set per hour while awake.
Group B: PEP – Blow bottle device group. A bottle with 10 cm of water and a 42cm plastic tube (1 cm diameter) will be used as the blow bottle. The maneuver gives will provide a resisted exhalation with an expiratory peak pressure of 10cm H2O. Subjects will be instructed to perform slow maximal inspirations, while expiration through the device, in the sitting position. The exercise included 3 sets of 10 deep breaths with 30 to 60 seconds pause between each set per hour while awake.
Group C: Conventional group Participants will be encouraged to continue routine physiotherapy techniques conducted by the ward staff. They will not be taught any extra breathing exercises.
The routine protocol consists of deep breathing exercises, breathing exercises using an incentive volumetric spirometer associated, coughing and huffing techniques. All participants will be encouraged to continue these exercises hourly while awake.
The exercise programme will be monitored through direct observation twice a day by the principal investigator and by the patient training diary maintained hourly while awake during the hospital. The participants will take the personal device to home after discharge from hospital for home breathing exercises. All the participants (all three groups) will be requested to continue the exercises for one month after surgery at home which will be encouraged through two phone calls weekly and will be monitored with exercise diaries.
Inclusion criteria
Male and female patients between 40 to 70 years of age awaiting CABG surgery at NHSL
Exclusion criteria
Exclusion criteria at point of recruitment
1. Other cardiovascular surgical procedure other than CABG Had a myocardial infarction within the past five days
2. Unstable angina
3. Patients with previous open heart surgery
4. Patients with hemodynamic instability –Blood pressure (BP) less than 110-70 mmHg, Heart rate 100-60, sinus rhythm
5. Uncooperative patients
6. Inability to consent or understand
7. Cognitive impairment
8. Diagnosed with cerebrovascular, orthopedic, neurologic, or cognitive-emotive disorders that would prevent the completion of the pre-surgical test items
9. Patients with COPD and any respiratory conditions
10. Any contraindication to use of PEP therapy e.g. severe haemoptysis, pneumothorax
Exclusion criteria at point of analysis
11. ICU time > 72 hours
12. Depend on mechanical ventilator for more than 24 hours
13. Need balloon pump more than 24 hours
14. Need ionotropic support more than 3 days
Primary outcome(s)
1.
Improvement of post-operative pulmonary function over baseline as determined by |
[ All primary outcomes will be measured |
Secondary outcome(s)
1.
|
[ All secondary outcomes will be measured |
Target number/sample size
Total number- 180: 60 patients will be recruited for each study group.Group A: commercialized PEP device group Group B: PEP blow bottle device group Group C: conventional group
Countries of recruitment
Sri Lanka
Anticipated start date
2018-03-01
Anticipated end date
2018-12-31
Date of first enrollment
Date of study completion
Recruitment status
Pending
Funding source
University of Colombo (Small Research Grant no AP/3/2/2017/SG/12)
Regulatory approvals
Status
Approved
Date of Approval
2017-06-15
Approval number
EC-16-215
Details of Ethics Review Committee
Name: | Ethics Review Committee, Faculty of Medicine, University of Colombo |
Institutional Address: | No. 25, Kynsey Road, Colombo 00800 Sri Lanka |
Telephone: | +94-11-2695300 (Extension: 240) |
Email: | ethicscommitteemfc@gmail.com |
Contact person for Scientific Queries/Principal Investigator
Ms. MDC Silva
Lecturer (Probationary)
Department of Physiotherapy, Faculty of Allied Health Sciences, General Sir John Kotelawala Defence University
Werahera, Sri Lanka
Mob: 0783639478
denikach@gmail.com
Contact Person for Public Queries
Dr. PM Atapatthu
Senior Lecturer
Department of Physiology
Faculty of Medicine, University of Colombo
Tel: +94112695300
Mob: +94779501610
piyushaatapattu@yahoo.com
Primary study sponsor/organization
University of Colombo
Cumaratunga Munidasa Mw
Colombo 03
Sri Lanka
Tel: (+94) 112 581 835
http://www.cmb.ac.lk/
Do the investigators plan to share identified individual clinical trial participant-level data (IPD)?
No
IPD sharing plan description
Study protocol available
Protocol version and date
Not Available
Protocol URL
Not Available
Results summary available
No
Date of posting results
Date of study completion
Final sample size
Date of first publication
Link to results
Brief summary of results